top of page

In the News


益福生醫PS128全球布局有成 獲台北生技獎國際躍進銀獎
益福生醫「精神益生菌PS128」在全球市場布局有成,銷售年年大幅成長,已成功簽約超過44國,終端產品目前已於全球超過28個市場成功上市。益福生醫採取在當地製造、因地制宜的靈活策略,得到歐美各國消費者的信賴,獲評審肯定,拿下2021年台北生技獎「國際躍進獎」銀獎殊榮。...


PS128對抑鬱症狀和睡眠品質的影響
26-AUG-2021 A study involving 40 insomniacs has found that daily administration of the probiotic Lactobacillus plantarum PS128 can reduce...


益福生醫研發團隊發表最新臨床研究精神益生菌可降低電子業從業人員工作壓力
(台北訊)為鼓勵中小企業創新、扶植研究,經濟部中小企業處推動多項新創補助,成果斐然。其中由國立陽明交通大學產學講座教授蔡英傑領軍的益福生醫研究團隊攜手國內醫學中心精神醫學部身心科醫師,首度推進腸腦軸線精神益生菌研究,將植物乳桿菌PS128應用至人體臨床研究,得到精神益生菌可...


台灣神經科權威陸清松醫師攜手蔡英傑教授發表最新成果益生菌可輔助改善帕金森氏病的動作障礙
(台北訊)有台灣帕金森之父之稱的陸清松醫師與益生菌權威蔡英傑教授合作進行一項「植物乳桿菌PS128對帕金森氏病治療的輔助作用」臨床研究,發現服用抗帕金森氏病的藥物時,若搭配精神益生菌PS128,可顯著縮短病人之「無藥效期」、延長藥效時間,並對活動性、生活自理能力及認知能力顯...
結合催產素和精神益生菌療法,新的臨床研究中有效改善自閉症症狀
TAIPEI, June 15, 2021 /PRNewswire/ A combination of oxytocin and a probiotic could synergistically improve symptoms of autism. These were...


Psychobiotic PS128 improves mood and sleep quality in its first clinical study on anxiety and stress
Bened Biomedical’s psychobiotic PS128 significantly improved insomnia, stress, and anxiety during a recent clinical trial. Participants...


食用精神益生菌PS128在新的臨床研究中顯示對帕金森症狀有益
TAIPEI, Feb. 18, 2021 /PRNewswire/ -- Bened Biomedical, a leading Taiwanese probiotic company, has announced a successful clinical study...


益福生醫執行長鄭勝德獲得AABI炬火最佳企業家獎
Bened CEO Frankie Cheng Wins AABI Torch Best Entrepreneur Award


益福生醫將 PS128™ 的獨家權利授予 M8 Pharmaceuticals
Its portfolio companies address the most compelling trends in global health. The firm is currently investing out of its sixth fund.


Blackmores Inc. 與精神益生菌供應商益福生醫達成協議
Bened has sealed a deal with the Blackmores Group to supply its proprietary probiotic strain PS128.


歐盟公司 BeoPanax 被選為獨家精神益生菌產品分銷商
EU firm Beopanax selected as exclusive psychobiotic product distributor
益福生醫透過新研究擴展在亞洲和歐洲的影響力
Psyched for psychobiotics: Bened increases reach in Asia and Europe with new study and proprietary strain
製藥公司與精神益生菌初創企業合作,首次進入微生物組調節領域
Neuraxpharm Group, a pharmaceutical firm focused on the central nervous system (CNS), has announced its first foray in the probiotics catego


益福生醫積極推動專有成分擴張計劃
Feb. 12, 2019 https://www.nutraingredients-asia.com/Article/2019/02/12/Psychobiotics-in-South-East-Asia-Bened-powering-through-with-expan...


用心思,隨直覺:益福生醫屢獲殊榮的益生菌產品準備上市
Sept. 17, 2018 The makers of a probiotic product targeting the gut-brain axis have highlighted research underlining how it can ease...


台灣揭示治療帕金森病的新發現
19 February 2021 | News In this pioneer study, PS128 was used as adjunct treatment for a group of twenty-five PD patients for three...


臨床研究證實精神益生菌PS128攝取對帕金森症狀有益
18 Feburary 2021 | PRNewsWire Bened Biomedical, a leading Taiwanese probiotic company, has announced a successful clinical study for its...


台灣之光「益福生醫」再次鍍金!執行長鄭勝德打造中西兼容的開放式企業文化,獨獲2020 AABI最佳企業家獎
打破益生菌僅能促進腸道健康的刻板印象,獨步全球、由本土團隊自主研發的精神益生菌PS128經證實能緩解情緒憂鬱,首年研究結果即躍登國際知名期刊《Nutrients》,日前更獲美國GRAS(Generally Recognized as...


全球十大精神益生菌關鍵企業名單出爐 台灣益福生醫入列
全球權威市場調查機構Future Market Insights (FMI) 2020年6月份發布最新研究報告「精神益生菌營養補充品市場: 2015-2019全球產業分析及未來十年機會評估」,其中,在當前全球十大精神益生菌關鍵企業(Psychobiotic...


精神益生菌PS128獲得美國GRAS安全性認證
Bened Biomedical Co. Ltd., a global leader of functional probiotics esp. psycho-biotics and REJMIUS, INC. proudly announce the newest Self-a
bottom of page

